MIRUM PHARMACEUTICALS AG

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company based in Foster City, California, dedicated to pioneering treatments for rare liver diseases. Mirum has one FDA-approved drug, the oral solution LIVMARLI™ (maralixibate), and a development pipeline with two additional therapies to advance the treatment of cholestatic liver disease in children and adults. Learn more about the company, its approved drugs and its ongoing clinical programs at www.mirumpharma.com.